Viewing Study NCT02755467


Ignite Creation Date: 2025-12-25 @ 12:29 AM
Ignite Modification Date: 2026-02-25 @ 5:35 PM
Study NCT ID: NCT02755467
Status: COMPLETED
Last Update Posted: 2023-03-24
First Post: 2016-04-25
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Clinical Evaluation of the Treatment of Spider Angioma
Sponsor: Cutera Inc.
Organization:

Study Overview

Official Title: A Clinical Evaluation of the Treatment of Spider Angioma Using a Dual Wavelength Laser Emitting 532 nm Laser Energy
Status: COMPLETED
Status Verified Date: 2023-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: To evaluate the safety and effectiveness of the laser treatment for the treatment of spider angiomas.
Detailed Description: The purpose of this study is to evaluate the safety and efficacy of the 532 nm KTP laser within the Cutera Excel V system for the treatment of spider angiomas.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: